Chief financial officer · Caribou Biosciences, Inc. (CRBU)

Jason O'Byrne

FY2021 is the first fiscal year CompBrief holds for Jason O'Byrne as a named executive officer of Caribou Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,449,030

Salary $358,580Bonus $227,775

2nd of 3 named executive officers at Caribou Biosciences by FY2021 total.

3 named officers on file for Caribou Biosciences, FY2021

Jason O'Byrne’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Caribou Biosciences’s whole pay program stands against its peers

  • Caribou Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRBU→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 11, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jason O'Byrne’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jason O'Byrne compensation by year

Caribou Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Caribou Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$358,580
Bonus$227,775
Option awards$2,862,675
Total$3,449,030

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Caribou Biosciences, Inc. DEF 14A filed August 11, 2022, accession 0000950170-22-016847, and prior-year filings.

How this page was built: the Caribou Biosciences, Inc. filed document, accession 0000950170-22-016847. Every figure is read from that document and cited to the page and table it appears in. Filed August 11, 2022.

Insider transactions since the last proxy

3 Form 4 lines since the FY2021 proxy (filed August 11, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-02-20Grant or award—33,000$0.0059,224
2024-02-20Grant or award derivative—153,000$0.00153,000
2023-02-21Grant or award derivative—131,000$0.00131,000

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Caribou Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Rachel HaurwitzPresident and chief executive officer$6,249,919
Jason O'Byrne · this pageChief financial officer$3,449,030
Barbara McClungChief legal officer and corporate secretary$2,743,054

The full Caribou Biosciences compensation record

free company brief

This page is one person within Caribou Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Caribou Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jason O'Byrne's compensation dossier · One-time report. No refunds.